No Data
Capitulation in Biotech Is Near, as Well as a Rally – Piper Sandler
Biotech and Retail ETFs Have the Highest Implied Call Return According to Goldman
Why Recursion Is Getting Love as an AI and Drug Discovery Top Pick
Biotech IPOs Return as Sector Recovers After Funding Overhang
Healthcare Venture Investors Ante Up. Public Markets Remain Cool. -- Barrons.com
SPDR S&P Biotech ETF Options Spot-On: On September 23rd, 113.56K Contracts Were Traded, With 981.1K Open Interest
On September 23rd ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 113.56K options for the day, of which put options accounted for 51.04% of the total